Comparison

BMS-265246

Item no. V1554-50mg
Manufacturer InvivoChem LLC
CASRN 582315-72-8
Amount 50 mg
Quantity options 100 mg 10 mg 250 mg 25 mg 500 mg 5 mg
Category
Type Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V1554CAS #:582315-72-8Purity >=98%

Description: BMS-265246 is a novel, potent and selective CDK1/2 inhibitor with IC50 of 6 nM/9 nM in a cell-free assay. It is 25-fold more selective for CDK1/2 than CDK4. BMS265246 inhibited the Cdk4/cycD activity and prevented A2780 Cytox (IC50 = 0.23 uM and 0.76 uM). In HCT-116 cells, BMS-265246 blocked the cell proliferation (EC50= 0.293 um—0.492 um). Following the treatment of BMS-265246, low DNA intensity, large round nuclei and 4N DNA content were observed in the dominant cell population –G2 arrested cells.

References: Bioorg Med Chem Lett. 2003 Jul 21; 13(14):2405-8; Mol Cancer Ther. 2011 Feb; 10(2):242-54.

Molecular Weight (MW)
345.34
Formula
C18H17F2N3O2
CAS No.
582315-72-8
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Solubility (In vitro)
DMSO: 20 mg/mL (57.9 mM)
Water: < 1 mg/mL
Ethanol: < 1 mg/mL
Solubility (In vivo)
30% PEG400+0.5% Tween80+5% Propylene glycol: 30 mg/mL
Synonyms
BMS265246; BMS-265246; BMS 265246; (4-butoxy-1H-pyrazolo[3, 4-b]pyridin-5-yl)(2, 6-difluoro-4-methylphenyl)methanone

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close